Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_assertion type Assertion NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_head.
- NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_assertion wasGeneratedBy ECO_0000203 NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_provenance.
- NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_assertion wasDerivedFrom befree-20140225 NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_provenance.
- NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_assertion SIO_000772 20721741 NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_provenance.
- NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_assertion evidence source_evidence_literature NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_provenance.
- NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_assertion description "[Specifically, in familial cancer syndromes, DHPLC has been reported as a genetic screening tool for the risk of developing breast and ovarian cancer (BRCA1), von Hippel Lindau disease (VHL), Cowden syndrome (PTEN), and Multiple Endocrine Neoplasia types 1 and 2 (MEN1 and RET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781497.RA_iu3OmUhEfGljLIhNr2mqMgljZkuSGYA9y05BiochFs130_provenance.